BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14992466)

  • 1. Interaction between smoking and glutathione S-transferase polymorphisms in solvent-induced chronic toxic encephalopathy.
    Ahmadi A; Jönsson P; Flodin U; Söderkvist P
    Toxicol Ind Health; 2002 Jul; 18(6):289-96. PubMed ID: 14992466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy.
    Söderkvist P; Ahmadi A; Akerbäck A; Axelson O; Flodin U
    Scand J Work Environ Health; 1996 Oct; 22(5):360-3. PubMed ID: 8923609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of smoking and metabolic enzyme polymorphisms in the organic solvent induced chronic encephalopathy].
    Wang HY; Ma YM; Cui JZ; Zhao D; Liu AJ; Hong J; Lu YG; Wang KJ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Mar; 34(3):199-202. PubMed ID: 27220440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD.
    Cheng SL; Yu CJ; Chen CJ; Yang PC
    Eur Respir J; 2004 Jun; 23(6):818-24. PubMed ID: 15218992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].
    Chen K; Jiang QT; Ma XY; Yao KY; Leng SG; Yu WP; Zhou HG
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):645-8. PubMed ID: 15777499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India.
    Kiran M; Chawla YK; Kaur J
    DNA Cell Biol; 2008 Dec; 27(12):687-94. PubMed ID: 18816171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
    Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
    Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
    Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
    Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk.
    Masetti S; Botto N; Manfredi S; Colombo MG; Rizza A; Vassalle C; Clerico A; Biagini A; Andreassi MG
    J Mol Med (Berl); 2003 Aug; 81(8):488-94. PubMed ID: 12811412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
    Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione s-transferase m1 and t1 polymorphisms and susceptibility to oxidative damage in healthy korean smokers.
    Lee SH; Park E; Park YK
    Ann Nutr Metab; 2010; 56(1):52-8. PubMed ID: 20029178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of prenatal solvent exposure and GSTT1 or GSTM1 polymorphisms in the risk of birth defects.
    Garlantézec R; Chevrier C; Coiffec I; Celebi C; Cordier S
    Birth Defects Res A Clin Mol Teratol; 2012 Jun; 94(6):481-5. PubMed ID: 22570144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
    Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.